+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

Hemophilia Market Analysis, By Type, By Product, By Treatment Type, By Therapy Type, Forecasts To 2027 - Product Thumbnail Image

Hemophilia Market Analysis, By Type, By Product, By Treatment Type, By Therapy Type, Forecasts To 2027

  • Report
  • July 2020
  • 157 pages
From
Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023) - Product Thumbnail Image

Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023)

  • Report
  • July 2019
  • 109 pages
From
von Willebrand Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027 - Product Thumbnail Image

von Willebrand Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027

  • Report
  • July 2019
  • 241 pages
From
Global Hemophilia Treatment Market: Growth, Trends, Competitive Landscape, and Forecasts - Product Thumbnail Image

Global Hemophilia Treatment Market: Growth, Trends, Competitive Landscape, and Forecasts

  • Report
  • January 2020
  • 110 pages
From
Octagam 2019 U.S. Promotional Audit Report - Product Thumbnail Image

Octagam 2019 U.S. Promotional Audit Report

  • Report
  • July 2020
  • 21 pages
From
Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product; Disease; Treatment Type; Therapy; End User, and Geography - Product Thumbnail Image

Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product; Disease; Treatment Type; Therapy; End User, and Geography

  • Report
  • February 2020
  • 225 pages
From
Hemophilia Treatment Market Research Report by Product Type, by Distribution, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 - Product Thumbnail Image

Hemophilia Treatment Market Research Report by Product Type, by Distribution, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • Report
  • June 2021
From
Hemophilia Market 2020-2026 - Product Thumbnail Image

Hemophilia Market 2020-2026

  • Report
  • August 2020
From
Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030 - Product Thumbnail Image

Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

  • Report
  • October 2019
  • 302 Pages
From
Von Willebrand Disease Treatment Market - Growth, Trends, and Forecasts (2020 - 2025) - Product Thumbnail Image

Von Willebrand Disease Treatment Market - Growth, Trends, and Forecasts (2020 - 2025)

  • Report
  • June 2020
  • 111 pages
From
Hemophilia Treatment Market by Type, by Product, and by Therapy: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025 - Product Thumbnail Image

Hemophilia Treatment Market by Type, by Product, and by Therapy: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025

  • Report
  • July 2019
  • 110 pages
From
Global Von Willebrand Disease Treatment Market 2019-2023 - Product Thumbnail Image

Global Von Willebrand Disease Treatment Market 2019-2023

  • Report
  • November 2018
  • 115 pages
From
Hemophilia Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025 - Product Thumbnail Image

Hemophilia Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • Report
  • August 2019
  • 100 pages
From
Obsessive-Compulsive Disorder (Central Nervous System) - Drugs in Development, 2021 - Product Thumbnail Image

Obsessive-Compulsive Disorder (Central Nervous System) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
From
Europe Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Europe Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • April 2021
  • 68 pages
From
Global Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Global Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • April 2021
  • 145 pages
From
LAMEA Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

LAMEA Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • April 2021
  • 67 pages
From
North America Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

North America Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • April 2021
  • 60 pages
From
Asia Pacific Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Asia Pacific Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • April 2021
  • 68 pages
From
The Corporate Reputation of Pharma in 2019 - The Patient Perspective Bleeding-Disorders Edition: The Views of 52 Bleeding-Disorders Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2019 - The Patient Perspective Bleeding-Disorders Edition: The Views of 52 Bleeding-Disorders Patient Groups

  • Report
  • July 2020
  • 33 Pages
Loading Indicator
adroll